PharmacyCodes



Dantafur en es it fr

Categoria

Dantafur Nombres de marca, Dantafur Analogos

Dantafur Marca los nombres de mezcla

  • No information avaliable

    • Dantafur Formula quimica

    C8H6N4O5

    Dantafur RX enlace

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Dantafur FDA hoja

    Dantafur MSDS (hoja de seguridad de materiales)

    Dantafur MSDS

    Dantafur Sintesis de referencia

    No hay información disponible

    Dantafur Peso molecular

    238.157 g/mol

    Dantafur Punto de fusion

    263 oC

    Dantafur H2O Solubilidad

    79.5 mg / L

    Dantafur Estado

    Solid

    Dantafur LogP

    -0.04

    Dantafur Formas de dosificacion

    Tableta

    Dantafur Indicacion

    Para el tratamiento de la infección del tracto urinario

    Dantafur Farmacologia

    Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.

    Dantafur Absorcion

    No hay información disponible

    Dantafur Toxicidad

    No hay información disponible

    Dantafur Informacion de Pacientes

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Dantafur Organismos afectados

    Gram negativos y algunas bacterias gram positivas